-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The mechanism of carcinoid heart disease (CaHD) is still unclear
.
For patients who did not have any heart involvement at baseline, it is difficult to determine their best timing for follow-up
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, this study aimed to assess the prevalence and natural history of CaHD by annual echocardiography
.
Researchers analyzed 137 consecutive patients (61±12 years old, 53% male) who were diagnosed with digestive endocrine tumors and carcinoid syndromes between 1997 and 2017
.
All patients underwent continuous routine transthoracic echocardiography
Digestion
The average follow-up time of subjects was 54±45 months
.
The prevalence of CaHD was 27% at baseline and 32% at the 5-year follow-up
Digestion
Thus, the results of the study indicate that in patients without CaHD initially, heart involvement may occur later and is related to serotonin levels
.
The data from this study underscores the need for cardiac follow-up in patients with tumor recurrence
The results of this study indicate that in patients without CaHD initially, cardiac involvement may occur later and is related to serotonin levels
Original source:
Emilie Baron,et al.